Gouws Capital LLC Danaher Corp Transaction History

Gouws Capital LLC

$140 Million
Q2 2024

A detailed history of Gouws Capital LLC transactions in Danaher Corp stock. As of the latest transaction made, Gouws Capital LLC holds 26,137 shares of DHR stock, worth $7.17 Million. This represents 4.67% of its overall portfolio holdings.

Number of Shares

26,137

Previous 25,058 4.31%

Holding current value

$7.17 Million

Previous $6.26 Million 4.36%

% of portfolio

4.67%

Previous 4.74%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$235.51 - $267.98 $254,115 - $289,150	1,079 Added 4.31%	26,137 $6.53 Million
Q1 2024 May 08, 2024	SELL	$224.58 - $256.19 $156,083 - $178,052	-695 Reduced 2.7%	25,058 $6.26 Million
Q4 2023 Jan 24, 2024	BUY	$185.1 - $233.13 $213,975 - $269,498	1,156 Added 4.7%	25,753 $5.96 Million
Q3 2023 Nov 13, 2023	SELL	$233.08 - $265.59 $227,253 - $258,950	-975 Reduced 3.81%	24,597 $6.1 Million
Q2 2023 Aug 03, 2023	BUY	$224.99 - $256.14 $112,495 - $128,070	500 Added 1.99%	25,572 $6.14 Million
Q1 2023 May 09, 2023	BUY	$239.75 - $277.0 $73,123 - $84,485	305 Added 1.23%	25,072 $6.32 Million
Q4 2022 Feb 08, 2023	BUY	$241.42 - $282.29 $53,836 - $62,950	223 Added 0.91%	24,767 $6.57 Million
Q3 2022 Oct 28, 2022	BUY	$247.06 - $1507.4 $48,670 - $296,957	197 Added 0.81%	24,544 $6.34 Million
Q2 2022 Jul 28, 2022	BUY	$237.11 - $299.66 $97,689 - $123,459	412 Added 1.72%	24,347 $6.17 Million
Q1 2022 Apr 26, 2022	BUY	$257.27 - $315.76 $200,670 - $246,292	780 Added 3.37%	23,935 $7.02 Million
Q4 2021 Feb 03, 2022	BUY	$292.08 - $329.01 $6.76 Million - $7.62 Million	23,155 New	23,155 $7.62 Million

Others Institutions Holding DHR

# of Institutions

2,388

Shares Held

563M

Call Options Held

3.94M

Put Options Held

4.1M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $200B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gouws Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gouws Capital LLC with notifications on news.

Account

Gouws Capital LLC Danaher Corp Transaction History